Professional Documents
Culture Documents
D<;@8>L@;<
U.S. Department of
Health and Human Services
National Institutes of Health
nnn%[il^XYlj\%^fm
_fnkfe[n_Xkpfle\\[
kfbefnXYflk[il^XYlj\
Xe[X[[`Zk`fe
Gi`ek\[8gi`c)''0
N_Xk N_f
EXk`feXc@ejk`klk\jf]?\Xck_
n`k_`ek_\L%J%;\gXikd\ekf]?\Xck_Xe[?ldXeJ\im`Z\jR;??JT
JZ`\eZ\f][il^Xe[e`Zfk`e\X[[`Zk`fe#gi\jZi`gk`fe
[il^XYlj\#gi\m\ek`feXe[ki\Xkd\ek#[il^XYlj\
Xe[?@M&8@;J#Xe[Dfe`kfi`e^k_\=lkli\Jlim\p
/k_#('k_#Xe[()k_^iX[\ij
EXk`feXc@ejk`klk\fe;il^8Ylj\E@;8
Press Oce. 30-443-24S
E-muil. mediu_nidu.nih.gov
Web. http.//www.nidu.nih.gov/NDANews.html
JZ`\eZ\f]XcZf_fclj\#X[[`Zk`fe#Xe[XYlj\2
[ileb[i`m`e^2Xe[]\kXcXcZf_fcjpe[ifd\
EXk`feXc@ejk`klk\fe8cZf_fc8Ylj\Xe[
8cZf_fc`jdE@888
Press Oce. 30-443-380
Web. http.//www.niuuu.nih.gov
JZ`\eZ\f]d\ekXc_\Xck_gi\m\ek`feXe[ki\Xkd\ek EXk`feXc@ejk`klk\f]D\ekXc?\Xck_E@D?
Press Oce. 30-443-4S3
Web. http.//www.nimh.nih.gov
Fk_\iI\c\mXek8^\eZ`\jN`k_`ek_\;??J
EXk`feXcJlim\pfe;il^Lj\Xe[?\Xck_#Ki\Xkd\ek
=XZ`c`kpCfZXkfi#Xe[Ki\Xkd\ek9cfZb>iXekj
JlYjkXeZ\8Ylj\Xe[D\ekXc?\Xck_
J\im`Z\j8[d`e`jkiXk`feJ8D?J8
Press Oce. 240-27-230
Web. http.//www.sumhsu.gov
JX]\kpXe[\]ZXZpf]d\[`ZXk`fej =ff[Xe[;il^8[d`e`jkiXk`fe=;8
Press Oce. 30-827-2S0
Web. http.//www.du.gov
Jdfb`e^gi\m\ek`feXe[Z\jjXk`fe2Xe[?@M&8@;J :\ek\ij]fi;`j\Xj\:fekifcXe[Gi\m\ek`fe
:;:#F]Z\feJdfb`e^Xe[?\Xck_
Press Oce. 202-39S-8
Web. http.//www.cdc.gov/mediu/
http.//www.cdc.gov/tobucco/
I\c\mXekF]Z\jFlkj`[\;??J
F]Z\f]EXk`feXc;il^:fekifcGfc`ZpFE;:G
Executive Oce o the President
Press Oce. 202-39S-8
Web. http.//www.whitehousedrugpolicy.gov
;il^<e]fiZ\d\ek8[d`e`jkiXk`fe;<8#
n`k_`ek_\L%J%;\gXikd\ekf]Aljk`Z\
Press Oce. 202-307-7977
Web. http.//www.deu.gov
9li\Xlf]Aljk`Z\JkXk`jk`Zj
Press Oce. 202-S4-2007
Web. http.//www.op.usdo.gov/bs/drugs.htm
PEPOP1EP'S QUCK PElEPENCE CUDE-WHO 1O CALL lOP WHA1
Dfi\[\kX`cjfegX^\+(%
quick reference/
drugs & health
K
?
<
9
8
J
@
:
J
:
F
E
K
8
:
K
J
I
<
J
F
L
I
:
<
J
8
9
F
L
K
E
@
;
8
>
C
F
J
J
8
I
P
k_\EXk`feXc@ejk`klk\fe;il^8Ylj\
D<;@8>L@;<
K?<98J@:J
( K_\JZ`\eZ\f];il^8Ylj\
Xe[8[[`Zk`fe1K_\9Xj`Zj
/ :fddfecp8Ylj\[;il^j
I<JFLI:<J
(5 N_\i\kf=`e[EXk`fen`[\Ki\e[j
Xe[JkXk`jk`Zj
(6 E@;8I\jfliZ\j
18 Fk_\i>fm\ied\ekN\YJ`k\j]fi
?\Xck_Xe[JZ`\eZ\@e]fidXk`fe
89FLKE@;8
19 E@;8j?`jkfipXe[9XZb^ifle[
>CFJJ8IP
:FEK8:KJ
T
H
E
B
A
S
I
C
S
C
O
N
T
A
C
T
S
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
G
L
O
S
S
A
R
Y
RESEARCH
FACTS
FIGURES
DEAR
JOURNALIST
We thank you for your interest in the vitally important
issues of drug abuse and addiction.
Today, thanks to science, our views and responses to addiction have changed
dramatically. After 30 years of research, as well as the development of exciting
new imaging technologies, we now know that drug addiction is a disease of the
brain that affects behaviora disease that can respond to treatment.
As the Director of the National Institute on Drug Abuse (NIDA), I am pleased
to offer this guide to the important fndings that are emerging as a result of
research on addiction and its treatment. NIDA, part of the National Institutes
of Health under the U.S. Department of Health and Human Services, supports
most of the worlds research on drug abuse and addiction, including basic
and behavioral science research that addresses fundamental and essential
questions relevant to drug abuse, ranging from its causes and consequences to
its treatment and prevention.
The purpose of this guide is to give journalists fast and user-friendly access to
the latest scientifc information. In more than three decades as a researcher, I
have seen the impact that science and health journalists have had in bringing
scientifc research to the public. It is through information that Americans gain
hope and understanding.
I have come to know many of you over the years and remain committed to
releasing scientifc information as quickly as possible for rapid dissemination to
the public. Please keep this guide nearby as a useful tool and let us know how
NIDAs public liaison staff can help you reach your information and deadline
needs.
Nora D. Volkow, M.D.
Director
National Institute on Drug Abuse
T
H
E
B
A
S
I
C
S
C
O
N
T
A
C
T
S
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
G
L
O
S
S
A
R
Y
We are committed to bringing timely,
factual information on addiction and
treatment to the press and public. NIDAs
Public Information and Liaison Branch
(PILB) is part of NIDAs Offce of Science
Policy and Communications. Linking
scientists, the scientifc community,
and the media, PILB supports the rapid
dissemination of research information
to inform policy and to improve practice.
NIDAs goal is to ensure that science
not ideology or anecdoteforms
the foundation of public information
on drug abuse and addiction.
Visit us online at www.drugabuse.gov
or call the NIDA Press Offce at
301-443-6245 for information and
access to experts, research, news, and
information.
This guide was developed by PILB as part
of the Institutes mission to close the gap
between the publics impressions about
drug abuse and the knowledge gained
from scientifc research on addiction and
substance abuse.
NIDAs Public Information and Liaison Branch:
NIDAs Link to the Media
the science of drug
abuse and addiction:
the basics
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
What is drug addiction?
Addiction is defned as a chronic,
relapsing brain disease that is
characterized by compulsive drug
seeking and use, despite harmful
consequences. It is considered a brain
disease because drugs change the brain;
they change its structure and how it
works. These brain changes can be long
lasting and can lead to many harmful,
often self-destructive, behaviors.
Why study drug abuse
and addiction?
Abuse of and addiction to alcohol,
nicotine, and illegal substances
cost Americans upwards of half a
trillion dollars a year (the combined
medical, economic, criminal, and
social impact). Every year, the abuse
of illicit drugs and alcohol contributes
to the death of more than 100,000
Americans, while tobacco is linked to an
estimated 440,000 deaths per year.
How are drug disorders
categorized?
The Diagnostic and Statistical Manual of
Mental Disorders (DSM) is a diagnostic
manual used by clinicians that contains
descriptions and symptoms of all
mental disorders classifed by the
American Psychiatric Association. The
DSM uses the term substance use
disorders to characterize illnesses
associated with drug use. There are
two broad categories: substance abuse
and substance dependence. Both
are associated with a maladaptive
pattern of substance use that leads to
clinically signifcant impairment. Drug
abuse includes such symptoms as:
failure to fulfll major role obligations;
legal problems;
use in situations that are
physically hazardous; and
continued use despite persistent
social or interpersonal problems.
The term dependence includes
such symptoms as:
drug taking in larger amounts
than intended;
inability to cut down on drug use;
a great deal of time spent in activities
necessary to obtain the drug; and
continued use despite knowledge
of health or social problems
caused by the drug.
THE SCIENCE OF DRUG ABUSE
AND ADDICTION: THE BASICS
1
T
H
E
B
A
S
I
C
S
C
O
N
T
A
C
T
S
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
G
L
O
S
S
A
R
Y
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
Dependence may or may not include
physical dependence, defned by
withdrawal symptoms when drug use
is abruptly ceased, and tolerance, the
need for more drug to achieve a desired
effect. The DSM term dependence is
what NIDA refers to as addiction.
What is the difference
between physical
dependence,
dependence, and
addiction?
Physical dependence is not equivalent
to dependence or addiction and may
occur with the chronic use of any
substance, legal or illegal, even when
taken as prescribed. It occurs because
the body naturally adapts to chronic
exposure to a substance (e.g., caffeine
or a prescription drug), and when that
substance is taken away, symptoms
can emerge while the body readjusts
to the loss of the substance. Physical
dependence can lead to craving for the
drug to relieve the withdrawal symptoms.
Drug dependence and addiction refer to
drug or substance use disorders, which
may include physical dependence but
must also meet additional criteria.
How does NIDA use
the terms drug abuse
and addiction?
NIDA defnes any illicit use of a
substance as drug abuse; this includes
the nonmedical use of prescription
drugs. NIDA defnes addiction as a
chronic, relapsing disease characterized
by compulsive drug seeking and use
despite harmful consequences as well as
neurochemical and molecular changes
in the brain. NIDAs use of the term
addiction corresponds roughly to the
DSM defnition of dependence. The
DSM does not use the term addiction.
How do drugs work
in the brain to
produce pleasure?
Nearly all drugs of abuse directly or
indirectly target the brains reward
system by fooding the circuit
with dopamine. Dopamine is a
neurotransmitter present in regions
of the brain that regulate movement,
emotion, cognition, motivation, and
feelings of pleasure. The overstimulation
of this system, which rewards our natural
behaviors, produces the euphoric effects
sought by people who abuse drugs and
teaches them to repeat the behavior.
Is drug abuse a
voluntary behavior?
The initial decision to take drugs is
mostly voluntary. However, when
addiction takes over, a persons ability
to exert self-control can become
seriously impaired. Brain imaging
studies from drug-addicted individuals
show physical changes in areas of the
brain that are critical for judgment,
decisionmaking, learning and memory,
and behavior control. Scientists
believe that these changes alter the
way the brain works and may help
explain the compulsive and destructive
behaviors of an addicted person.
Can addiction be
treated successfully?
Yes. Addiction is a treatable, chronic
disease that can be managed
successfully. Research shows that
combining behavioral therapy with
medications, where available, is the
best way to ensure success for most
patients. Treatment approaches must
be tailored to address each patients
drug abuse patterns and drug-related
medical, psychiatric, and social problems.
Does relapse to
drug abuse mean
treatment has failed?
No. The chronic nature of the disease
means that relapsing to drug abuse
is not only possible but also likely.
Relapse rates are similar to those
for other well-characterized chronic
medical illnesses, such as diabetes,
hypertension, and asthma, which
also have both physiological and
behavioral components. Treatment of
chronic diseases involves changing
deeply imbedded behaviors. For the
addicted patient, lapses back to drug
abuse indicate that treatment needs
to be reinstated or adjusted or that
alternate treatment is needed.
How many people
die from drug use?
The CDC reports that there were almost
28,000 unintentional drug overdose
deaths in the United States in 2007.
3 2
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
Relapse rates for drug-addicted patients are compared with those suffering from
diabetes, hypertension, and asthma. Relapse is common and similar across these illnesses
(as is adherence to medication). Thus, drug addiction should be treated like any other
chronic illness, with relapse serving as a trigger for renewed intervention.
Source: McLellan et al., JAMA, 284:16891695, 2000.
Compari son of Rel apse Rates
Between Drug Addi cti on and
Other Chroni c I l l nesses
DRUG ADDI CTI ON
40 to 60%
TYPE I DI ABETES
30 to 50%
HYPERTENSI ON
50 to 70%
ASTHMA
50 to 70%
Percentage of Pati ents Who Rel apse
55 4
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
Prevalence of Past-Year
Drug Use Among
12
th
Graders
36. 4%
MARI JUANA/
HASHI SH
8. 2%
AMPHETAMI NES
8.1%
VI CODI N*
5. 3%
MDMA
(ECSTASY)
4.9%
OXYCONTI N*
2. 6%
RI TALI N*
1. 4%
GHB
1. 3%
PCP
1. 7%
KETAMI NE
2. 6%
COCAI NE
POWDER
4. 3%
SEDATI VES*
2. 7%
LSD
2.9%
COCAI NE
(ANY FORM)
3. 2%
I NHALANTS
* nonmedical use
6
2011 MONI TORI NG THE
FUTURE SURVEY
Findings from recent Monitoring the Future
(MTF) surveys indicate that prescription drugs
and over-the-counter cough syrup are among
the most abused drugs by 8th, 10th and 12th
graders. On the facing page is a graphic that
indicates drug use among 12th graders:
7
1. 0%
CRACK
1. 2%
I CE
1. 2%
STEROI DS*
5.9%
SALVI A
5. 6%
TRANQUI LI ZERS
6. 5%
ADDERALL
1. 4%
METH-
AMPHETAMI NE
1. 3%
ROHYPNOL
5. 3%
COUGH
MEDI CI NE*
7 6
11. 4%
SPI CE/K2
0. 8%
HEROI N
Cocaine
Cocaine is a short-acting stimulant,
which can lead abusers to binge
(to take the drug many times in a single
session). Cocaine abuse can lead to
severe medical consequences related to
the heart and the respiratory, nervous,
and digestive systems.
8th
Graders
10th
Graders
12th
Graders
Lifetime 2.2 3.3 5.2
Past Year 1.4 1.9 2.9
Past Month 0.8 0.7 1.1
Monitoring the Future is updated
annually. For the latest Monitoring
the Future statistics on cocaine please
visit www.nida.nih.gov/Infofacts/
HSYouthtrends.html.
For more information about cocaine use
and its health consequences, go to
www.nida.nih.gov/drugpages/
cocaine.html.
Marijuana
Marijuana is the most commonly abused
illicit substance. This drug impairs
short-term memory and learning, the
ability to focus, and coordination. It
also increases heart rate, can harm
the lungs, and may increase the risk of
psychosis in vulnerable individuals.
8th
Graders
10th
Graders
12th
Graders
Lifetime 16.4 34.5 45.5
Past Year 12.5 28.8 36.4
Past Month 7.2 17.6 22.6
Monitoring the Future is updated
annually. For the latest Monitoring the
Future statistics on marijuana please
visit www.nida.nih.gov/Infofacts/
HSYouthtrends.html.
For more information about marijuana
use and its health consequences, go to
www.nida.nih.gov/drugpages/
marijuana.html.
Concerns about the use of synthetic
cannabinoids (also known as Spice or
K2) prompted its inclusion in the 2011
Monitoring the Future survey, which
found that 11.4 percent of 12th-graders
reported past year use. For more
information about Spice, go to: www.
drugabuse.gov/infofacts/Spice.html.
COMMONLY
ABUSED DRUGS
Cigarettes
Nicotine is an addictive stimulant found
in cigarettes and other forms of tobacco.
Tobacco smoke increases a users risk of
cancer, emphysema, bronchial disorders,
and cardiovascular disease. The mortality
rate associated with tobacco addiction
is staggering. Tobacco use killed
approximately 100 million people during
the 20th century and, if current smoking
trends continue, the cumulative death
toll for this century is projected to reach
1 billion.
8th
Graders
10th
Graders
12th
Graders
Lifetime 18.4 30.4 40.0
Past Month 6.1 11.8 18.7
Daily 2.4 5.5 10.3
Monitoring the Future is updated
annually. For the latest Monitoring the
Future statistics on nicotine please
visit www.nida.nih.gov/Infofacts/
HSYouthtrends.html.
For more information about nicotine use
and its health consequences, go to
www.nida.nih.gov/drugpages/
nicotine.html.
Heroin
Heroin is a powerful opiate drug that
produces euphoria and feelings of
relaxation. It slows respiration and can
increase the risk of serious infectious
diseases, especially when taken
intravenously. Other opioid drugs include
morphine, OxyContin, Vicodin, and
Percodan, which have legitimate medical
uses; however, their nonmedical use or
abuse can result in the same harmful
consequences as heroin abuse.
8th
Graders
10th
Graders
12th
Graders
Lifetime 1.2 1.2 1.4
Past Year 0.7 0.8 0.8
Past Month 0.4 0.4 0.4
Monitoring the Future is updated
annually. For the latest Monitoring
the Future statistics on heroin please
visit www.nida.nih.gov/Infofacts/
HSYouthtrends.html.
For more information about heroin use
and its health consequences, go to
www.nida.nih.gov/drugpages/
heroin.html.
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
9 8
Prescription and Over-
the-Counter Medications
Prescription medications and some over-
the-counter medications are increasingly
being abused (used for nonmedical
purposes). This practice can be addictive,
and in some cases, lethal. Among
the most disturbing aspects of this
emerging trend is its prevalence among
teenagers and young adults, as well as
the common misperception that because
physicians prescribe these medications,
they are safe even when used not as
prescribed. Commonly abused classes
of prescription drugs include opioid
painkillers, stimulants, and depressants.
Commonly abused prescription
drugs include:
Opioids are usually prescribed for
pain relief. Commonly prescribed
opioids include hydrocodone (e.g.,
Vicodin), oxycodone (e.g., OxyContin),
morphine, fentanyl, and codeine.
Stimulants: Methylphenidate (Ritalin,
Concerta, Focalin, and Metadate) and
amphetamines (Adderall, Dexedrine)
are stimulants commonly prescribed
for attention-defcit hyperactivity
disorder.
Depressants are usually prescribed to
promote sleep or to reduce anxiety.
As measured by national surveys,
depressants are often categorized as
sedatives or tranquilizers. Sedatives
primarily include barbiturates
(e.g., phenobarbitol) but also
comprise sleep medications such as
Ambien and Lunesta. Tranquilizers
primarily include benzodiazepines
such as Valium and Xanax, but
also include muscle relaxants and
other anti-anxiety medications.
Amphetamines
Amphetamines, including
methamphetamine, are powerful
stimulants that can produce
feelings of euphoria and alertness.
Methamphetamines effects are
particularly long lasting and harmful
to the brain. Amphetamines can cause
high body temperature and can lead to
serious heart problems and seizures.
Monitoring the Future is updated
annually. For the latest Monitoring the
Future statistics on amphetamines
please visit www.nida.nih.gov/
Infofacts/HSYouthtrends.html.
For more information about
methamphetamine use and its health
consequences, go to www.nida.nih.gov/
drugpages/methamphetamine.html.
COMMONLY
ABUSED DRUGS
(continued)
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
8th
Graders
10th
Graders
12th
Graders
Opiate Painkillers
OxyContin
Past Year 1.8 3.9 4.9
Vicodin
Past Year 2.1 5.9 8.1
Sedatives
1
Lifetime --- --- 7.0
Past Year --- --- 4.3
Past Month --- --- 1.8
Tranquilizers
2
Lifetime 3.4 6.8 8.7
Past Year 2.0 4.5 5.6
Past Month 1.0 1.9 2.3
ADHD Medications
Adderall
Past Year 1.7 4.6 6.5
Ritalin
Past Year 1.3 2.6 2.6
Cough or Cold Medicines
3
Past Year 2.7 5.5 5.3
Methamphetamine
Lifetime 1.3 2.1 2.1
Past Year 0.8 1.4 1.4
Past Month 0.4 0.5 0.6
Amphetamines
Lifetime 5.2 9.0 12.2
Past Year 3.5 6.6 8.2
Past Month 1.8 3.1 3.7
1
Also known as downers and sleeping aids.
2
The most commonly reported drugs in this category are Valiumand Xanax.
3
Used with the intent to get high.
11 10
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
Anabolic Steroids
Steroids, which can also be prescribed
for certain medical conditions, are
abused to increase muscle mass and to
improve athletic performance or physical
appearance. Serious consequences of
abuse can include heart disease, liver
problems, stroke, infectious diseases,
depression, and suicide. Less serious side
effects include severe acne.
8th
Graders
10th
Graders
12th
Graders
Lifetime 1.2 1.4 1.8
Past Year 0.7 0.9 1.2
Past Month 0.4 0.5 0.7
Monitoring the Future is updated
annually. For the latest Monitoring the
Future statistics on anabolic steroids
please visit www.nida.nih.gov/
Infofacts/HSYouthtrends.html.
For more information about anabolic
steroid use and its health consequences,
go to www.nida.nih.gov/drugpages/
steroids.html.
Inhalants
Inhalants are volatile substances found
in many household products (such as
oven cleaners, gasoline, spray paints,
and other aerosols) that induce mind-
altering effects. Inhalants are extremely
toxic and can damage the heart, kidneys,
lungs, and brain. Even a healthy person
can suffer heart failure and death within
minutes of a single session of the
prolonged sniffng of an inhalant.
8th
Graders
10th
Graders
12th
Graders
Lifetime 13.1 10.1 8.1
Past Year 7.0 4.5 3.2
Past Month 3.2 1.7 1.0
Monitoring the Future is updated
annually. For the latest Monitoring the
Future statistics on inhalants please
visit www.nida.nih.gov/Infofacts/
HSYouthtrends.html.
For more information about inhalant use
and its health consequences, go to
www.nida.nih.gov/drugpages/
inhalants.html.
Alcohol
Alcohol consumption can damage the
brain and most body organs. Areas of the
brain that are especially vulnerable to
alcohol-related damage are the cerebral
cortex (largely responsible for our higher
brain functions, including problemsolving
and decisionmaking), the hippocampus
(important for memory and learning), and
the cerebellum (important for movement
coordination).
8th
Graders
10th
Graders
12th
Graders
Lifetime 33.1 56.0 70.0
Past Year 26.9 49.8 63.5
Past Month 12.7 27.2 40.0
Monitoring the Future is updated annually.
For the latest Monitoring the Future
statistics on alcohol please visit www.nida.
nih.gov/Infofacts/HSYouthtrends.html.
For more information about alcohol
use and its health consequences,
visit the National Institute on
Alcohol Abuse and Alcoholism
Web site at www.niaaa.nih.gov.
Club Drugs and
Hallucinogens
Ecstasy (MDMA) produces both stimulant
and mind-altering effects. It can increase
body temperature, heart rate, blood
pressure, and heart-wall stress. Ecstasy
may also be toxic to nerve cells.
8th
Graders
10th
Graders
12th
Graders
Lifetime 2.6 6.6 8.0
Past Year 1.7 4.5 5.3
Past Month 0.6 1.6 2.3
LSD is one of the most potent
hallucinogenic, or perception-altering,
drugs. Its effects are unpredictable, and
abusers may see vivid colors and images,
hear sounds, and feel sensations that seem
real but do not exist. Abusers also may
have traumatic experiences and emotions
that can last for many hours. Some
short-term effects can include increased
body temperature, heart rate, and blood
pressure; sweating; loss of appetite;
sleeplessness; dry mouth; and tremors.
8th
Graders
10th
Graders
12th
Graders
Lifetime 1.7 2.8 4.0
Past Year 1.1 1.8 2.7
Past Month 0.5 0.7 0.8
COMMONLY
ABUSED DRUGS
(continued)
13 12
resources
Club Drugs and
Hallucinogens
(continued)
Rohypnol and GHB are predominantly
central nervous system (CNS)
depressants. Because they are
often colorless, tasteless, and
odorless, they can be easily added to
beverages and ingested unknowingly.
Thus, these drugs have come to
be known as date rape drugs.
Monitoring the Future is updated
annually. For the latest Monitoring the
Future statistics on club drugs, please
visit www.nida.nih.gov/Infofacts/
HSYouthtrends.html.
For more information about these and
other club drugs go to www.nida.nih.gov/
drugpages/clubdrugs.html.
COMMONLY
ABUSED DRUGS
(continued)
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
Salvia
Past Year 1.6 3.9 5.9
8th
Graders
10th
Graders
12th
Graders
Rohypnol
Lifetime 2.0 1.2 ---
Past Year 0.8 0.6 1.3
Past Month
0.6 0.3
---
GHB
Past Year 0.6 0.5 1.4
Ketamine
Past Year 0.8 1.2 1.7
14
A
B
O
U
T
N
I
D
A
WHERE TO FIND NATIONWIDE
TRENDS AND STATISTICS
Major sources of data on the extent of
drug use in the United States include the
following:
Monitoring the Future (MTF)
The MTF study measures drug, alcohol,
and cigarette use and related attitudes
among adolescent students nationwide.
Survey participants report their drug
use behaviors across three time periods:
lifetime, past year, and past month. The
annual survey is funded by NIDA and is
conducted by the University of Michigan.
Results from the survey are released late
each fall. For the latest survey results, go
to: www.drugabuse.gov/DrugPages/
MTF.html.
Community Epidemiology
Work Group (CEWG)
CEWG provides current descriptive
and analytical information regarding
the nature and patterns of drug
abuse, emerging trends of drug
use, characteristics of vulnerable
populations, and the social and health
consequences. CEWG is a NIDA-
sponsored network of researchers from
20+ major U.S. metropolitan areas and
selected foreign countries who meet
semiannually to discuss the current
epidemiology of drug abuse (www.
nida.nih.gov/about/organization/
CEWG/CEWGHome.html).
National Survey on Drug
Use and Health (NSDUH)
The Substance Abuse and Mental Health
Services Administrations (SAMHSA)
NSDUH (formerly called the National
Household Survey on Drug Abuse) is
the primary source of information on the
prevalence, patterns, and consequences
of alcohol, tobacco, and illegal drug use
and abuse in the general U.S. civilian
noninstitutionalized population, ages 12
and older.Survey information can be found
at: www.oas.samhsa.gov/nsduh.htm.
Drug Abuse Warning
Network (DAWN)
The DAWN report, also prepared by
SAMHSA, provides information about
the impact of drug use on hospital
emergency departments in the United
States. It reports the number of visits to
the emergency department that were
related directly to the use of an illegal
drug or the nonmedical use of a legal
drug. DAWN is not a measure of the
prevalence of use but instead offers
information complementary to the
prevalence data found in the NSDUH
(www.samhsa.gov/oas/dawn).
15
A
B
O
U
T
N
I
D
A
Treatment Episode Data Set
(TEDS)
The TEDS system includes records for
approximately 1.5 million substance
abuse treatment admissions annually.
While TEDS does not represent all
substance abuse treatment activities,
it comprises a signifcant proportion
of all admissions to substance abuse
treatment programs and includes those
admissions that rely on public funds.
Data are reported by sex, age, and race/
ethnicity for each of 15 substance abuse
categories. TEDS is maintained by the
Offce of Applied Studies, SAMHSA
(wwwdasis.samhsa.gov/webt/
information.htm).
A wealth of material regarding various
aspects of drug abuse and addiction
is available, free of charge, from NIDA.
Most of the following materials are
available on the NIDA Web site. In
addition to these publications, many
reportssuch as the Directors report
to NIDAs National Advisory Council on
Drug Abuseare available online. The
following materials are among those
available from NIDA.
Please visit www.drugabuse.gov to
view NIDAs publications.
NIDA InfoFacts
NIDA InfoFacts is an online series of fact
sheets on specifc drugs, trends in use,
and prevention and treatment issues.
The fact sheets are available in English
and Spanish. They are written for use by
the general public (www.nida.nih.gov/
Infofacts/index.html).
NIDA Research Reports
This series of reports simplifes research
fndings for the educated lay public,
legislators, educational groups, and
practitioners. The series reports on
research fndings of national interest,
such as prescription drug abuse, tobacco
addiction, and HIV/AIDS. Research
Reports are also available in Spanish
(www.nida.nih.gov/ResearchReports/
ResearchIndex.html).
NIDA RESOURCES
NIDA Notes
NIDA Notes, published bimonthly, is the
Institutes major vehicle for relaying
research fndings to the feld in a timely
manner. It covers the areas of treatment
and prevention research, epidemiology,
neuroscience, behavioral research, health
services research, and HIV/AIDS. The
publication reports on advances in the
drug abuse feld; identifes NIDA research
priorities and opportunities; promotes
an exchange of information; and seeks
to improve communication among
clinicians, researchers, administrators,
and policymakers (www.nida.nih.gov/
NIDA_Notes/NNindex.html).
Addiction Science &
Clinical Practice
The Institutes Journal, Addiction Science
& Clinical Practice, published biannually,
promotes dialogue between scientists
and addiction treatment professionals,
with the aim of improving drug abuse
treatment and research. The journals
exchange of information, observations,
and insights helps clinicians make the
most of their programs and achieve
better treatment outcomes while
providing researchers with tools to
construct new hypotheses and to design
studies highly relevant to the needs of
providers and patients (www.nida.nih.
gov/Perspectives/index.html).
NIDA Web Site
Through its online presence, NIDA
strives to communicate its research
fndings to the wide-ranging audiences
it serves, which include students,
parents, teachers, researchers, scientists,
prevention and treatment practitioners,
health care professionals, policymakers,
constituent groups, children and
adolescents, underserved populations,
and the general public.
Most of NIDAs publications are available
on NIDAs Web site: www.drugabuse.gov.
Special features include:
Whats New, a link to the latest
NIDA materials available online
NIDA news releases
Upcoming NIDA-sponsored
meetings and conferences
International activities related
to research on drug abuse and
addiction
NIDA organizational units and
funding information
NIDA materials available in Spanish
Public service announcements
Other NIDA sites:
www.teens.drugabuse.gov
www.backtoschool.drugabuse.gov
www.hiv.drugabuse.gov
www.steroidabuse.gov
www.inhalants.drugabuse.gov
17 16
A
B
O
U
T
N
I
D
A
OTHER GOVERNMENT WEB SITES FOR
HEALTH AND SCIENCE INFORMATION
about NIDA
NIH (www.nih.gov)
NIH is the steward of medical and
behavioral research for the Nation.
Its mission is science in pursuit of
fundamental knowledge about the nature
and behavior of living systems and the
application of that knowledge to extend
healthy life and to reduce the burdens of
illness and disability. NIH is part of the
U.S. Department of Health and Human
Services (DHHS).
NLM (www.nlm.nih.gov)
NLM is the worlds largest library dealing
with a single scientifc/professional
topic. It cares for more than 4.5 million
holdings (including books, journals,
reports, manuscripts, and audiovisual
items) and sponsors MedlinePlus, a
source of up-to-date, quality health care
information from NLM and NIH.
Healthfnder
(www.healthfnder.gov)
Healthfnder is a gateway consumer
health information Web site from DHHS.
NWHIC (www.4women.gov)
NWHIC is a national clearinghouse for
womens health information, sponsored
by the Offce on Womens Health within
DHHS. NWHIC is the only Federal,
commercial-free, combined womens
health Web site and toll-free phone
information center.
18
NIDAS HISTORY
AND BACKGROUND
Research Accomplishments
Keeping an eye on drug use trends
among teens to guide intervention
strategies. Substance abuse among
American youth is a continually changing
phenomenon. Through the Monitoring
the Future Survey of 8th-, 10th-, and
12th-grade students nationwide, NIDA
continues to monitor these changes
and identify emerging substance abuse
problems to better guide effective
intervention approaches. For example,
while overall teen drug abuse showed a
signifcant decline from the mid-1990s
to the mid to late 2000s, recent years
have seen an upward trend in marijuana
use.
Identifying the molecular sites and
systems in the brain where every major
drug of abuse has its effect. Such
discoveries have led to the development
and approval of nicotine replacement
therapies for cigarette smoking cessation
and new medications like buprenorphine,
now prescribed by physicians in offce
settings for opiate addiction.
Discovering a new communications
network that opens the way to novel
medical therapies. NIDA-supported
research was pivotal to the discovery
of a cannabinoid system distributed
throughout the brain and body and
composed of the bodys own compounds
that are chemically related to marijuanas
active ingredient. This network promises
new and novel interventions for a range
of diseases and conditions, including
addiction, obesity, pain, osteoporosis,
multiple sclerosis, and anxiety disorders.
Demonstrating that addiction is a
treatable disease. Medications and
behavioral therapies can provide long-
lasting benefts for people trying to
overcome addiction, especially when
used together. Addiction treatment
promotes continued abstinence, which
can reverse some of the detrimental brain
changes caused by addiction, as shown
in pioneering imaging studies. Successful
drug abuse treatment also reduces crime
and other societal costs, including health
costs, now in the billions.
19
Optimizing research fndings to create
individually tailored treatments.
Researchers are taking advantage of
ongoing discoveries from the Human
Genome Project, identifying genetic
markers of complex disorders, such
as addiction. Now, gene variants are
being discovered that can predict who
will respond to a medication and who
will not. These breakthroughs herald a
new era of individualized therapies that
will optimize outcomes, promote cost-
effciency, and relieve suffering.
Decreasing the spread of HIV.
Through the development of treatments
for injection drug use (IDU), NIDA
has contributed to the decline in IDU-
associated HIV infections. Innovative
community-based research shows
that drug abuse treatment reduces risk
behaviors leading to HIV transmission;
thus, drug abuse treatment is HIV/AIDS
prevention.
Changing the course of drug abuse
treatment in this country. NIDA engages
in myriad efforts to translate the
results of basic and clinical research
for real-world use. Our goal is to get
research-based treatments into the hands
of providers in community treatment
centers, the criminal justice system, and
physicians offces. To that end, NIDA
has established collaborative networks
of researchers and practitioners, Federal
agencies, and State substance abuse
directors to integrate research fndings
into drug abuse treatment settings
nationwide.
Decade of NIDA Outreach
and Education Activities
1985: NIDA publishes the frst issue of
its bimonthly newsletter, NIDA Notes,
now disseminating research fndings to
100,000 professionals worldwide.
1990: NIDA launches Get High, Get
Stupid, Get AIDS, a public awareness
campaign directed at young adults
emphasizing how drug abuse can impair
judgment and can lead to risky sexual
behavior.
1992: NIDA publishes If You Change Your
Mind, a video documentary produced
by middle school students about drug
abuse. The package came with a student
magazine and teachers guide.
1995: NIDA
publishes
Marijuana:
Facts for Teens
and Marijuana:
Facts Parents
Need to Know,
two of NIDAs
most popular
publications.
(Updated
versions are still
available.)
1997: NIDA
releases
Preventing Drug
Use Among
Children and
Adolescents: A
Research-Based
Guide, which
described the
most successful
concepts for
preventing
drug abuse among young people. The
prevention principles were updated in
2003.
1997: NIDA
launches the
annual PRISM
Awards for
the accurate
depiction of
drugs, alcohol,
and tobacco in
feature flms
and television
productions.
The PRISM
Awards were
created as a
high profle, 10-year program.
1997: NIDA releases the Mind Over
Matter series for grades 5 through 9.
The series, complete with a teachers
guide, highlights the effects of drugs on
the brain and encourages the study of
science. This popular series is still in use
and was translated into Spanish in 2006.
1999: NIDA releases Principles of
Drug Addiction Treatment: A Research-
Based Guide, developed for use in local
communities. The guide describes the
most successful concepts for treating
people with drug abuse and addiction
problems. The Principles were updated in
early 2009.
1999: NIDA launches the NIDA Goes to
School initiative to provide middle school
students with accurate information
on how drugs affect the brain. More
than 18,000 middle schools across
the country received materials during
the launch year. In following years, the
project was renamed NIDA Goes Back to
School.
2000: NIDA launches Blending
Clinical Practice and Research:
Forging Partnerships to Enhance Drug
Addiction Treatment Research. In
2003, the Blending Initiative evolved
into a partnership with the Substance
Abuse and Mental Health Services
Administration to accelerate the
dissemination of research-based
treatment fndings into community-
based practice. By 2008, the Blending
Initiative had produced six products,
including materials on buprenorphine
treatment, motivational interviewing,
and the Addiction Severity Index for
treatment planning.
2000: NIDA launches its Bright and
Choices public service announcements
as part of its campaign to increase
knowledge that addiction is a brain
disease.
Revised
national institute
on drug abuse
national institutes
of health
NIH Publication No. 04-4212(B)
Printed 1997
Reprinted 1997, 1999, 2001
Second Edition October 2003
Preventing Drug Use
among Children and Adolescents
A Research-Based Guide
for Parents, Educators, and
Community Leaders
U.S. DEPARTMENT OF
HEALTH AND HUMAN SERVICES
National Institutes of Health
Second Edition
In Brief
National Institute on Drug Abuse
21 20
T
H
E
B
A
S
I
C
S
C
O
N
T
A
C
T
S
R
E
S
O
U
R
C
E
S
A
B
O
U
T
N
I
D
A
G
L
O
S
S
A
R
Y
2000: NIDA
distributes
its Clinical
Toolbox, a
collection of
science-based
materials
on drug
addiction and
its treatment,
to the nearly
12,000 drug
treatment programs nationwide.
2002: The Institute launches its frst
peer-reviewed journal, Science &
Practice Perspectives, to encourage more
collaboration between researchers and
practitioners. The journals name was
changed to Addiction Science & Clinical
Practice in 2008.
2002: NIDA
releases
the new
elementary
school
curriculum
Brain Power!
The NIDA
Junior Scientist
Program, for use in 2nd- and 3rd-grade
classrooms. Curricula for grades K1 and
45 were developed by 2007.
2002: NIDA teams with Scholastic, a
leading provider of educational materials
for children and teachers, to bring
ongoing science-based information
about drug abuse to millions of U.S.
school children.
2002: NIDA releases Principles of HIV
Prevention in Drug-Using Populations:
A Research-Based Guide, to help
communities prevent the spread of HIV.
2002: NIDA launches its Game Plan
public awareness campaign to remind
young people about the dangers of using
steroids to enhance performance.
2003: NIDA launches its interactive
Web site, NIDA for Teens: The Science
Behind Drug Abuse.
2005: NIDA launches the Drug Abuse
and HIV: Learn the Link campaign
to educate young people about the
connection between substance abuse
and HIV infection. The Spanish-language
version launched in 2007.
2006: NIDA
launches
Principles of Drug
Abuse Treatment
for Criminal Justice
Populations:
A Research-
Based Guide,
summarizing
proven
components
for successfully
treating drug abusers who have entered
the criminal justice system.
2007: NIDA holds its frst annual DRUG
FACTS CHAT DAY, an online opportunity
for students from around the country to
ask questions about drugs and to have
them answered by top NIDA scientists.
High school students in schools from 49
States, the District of Columbia, Puerto
Rico, the U.S. Virgin Islands, and Guam
submitted more than 36,000 questions
on a wide range of drug abuse-related
topics.
2007: NIDA releases its frst plain-
language booklet explaining the science
behind addiction. Drugs, Brains, and
BehaviorThe Science of Addiction
discusses the reasons that people
take drugs, why some people become
addicted while others do not, how drugs
work in the brain, and how addiction
can be prevented and treated. The
booklet is designed to educate the public
and to reduce the stigma surrounding
drug addiction.
9
8
J
@
:
J
I
<
J
F
L
I
:
<
J
8
9
F
L
K
E
@
;
8
>
C
F
J
J
8
I
P
:
F
E
K
8
:
K
J
;il^<e]fiZ\d\ek8[d`e`jkiXk`fe;<8
n`k_`ek_\L%J%;\gXikd\ekf]Aljk`Z\
1he DEA enorces the controlled substunces luws
und regulutions o the United Stutes. Although the
DEA shures inormution with NDA on drug supply
issues, questions concerning investigutions into drug
trucling, the diversion o phurmuceuticuls, or drug-
reluted criminul uctivity should be reerred to the
DEA press oce.
DEA Press Oce. 202-307-7977
Web. http.//www.deu.gov
9li\Xlf]Aljk`Z\JkXk`jk`Zj9AJ
8JS is un invuluuble resource or dutu reluted to drug
ubuse und crime. 8JS shures its dutu with NDA us
purt o NDA's ongoing initiutive to provide eective
drug treutment within the criminul ustice system.
8JS Press Oce. 202-S4-2007
Web. http.//www.op.usdo.gov/bs/drugs.htm
36